Evidence map›Paper›PMID 40825168›Full record

ArticleJCO precision oncology2025

Limitations of Radiographic Response Assessments of Systemic Therapy for Advanced Hepatocellular Carcinoma.

Kelsey S Lau-Min, Joseph W Franses

Abstract readEditorial
In one paragraph

Article in JCO precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kelsey S Lau-MinDivision of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.ORCID 0000-0001-8854-224X
Joseph W FransesDepartment of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL.ORCID 0000-0002-2517-4950

Funding

Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical OncologyK12CA087723 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI David Tsai Ting · 2002 to 2026
$17.9M
Defining pro-metastatic and endothelial-regulatory roles for LIN28B in hepatocellular carcinomaK08CA263551 · NCI · UNIVERSITY OF CHICAGO · PI Joseph Wang Franses · 2022 to 2026
$1.3M
NCI NIH HHS K08 CA263551NCI NIH HHS K12 CA087723
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40825168
PMCPMC12363656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.